Cemdisiran, a potential new drug for the treatment of generalized myasthenia gravis, has been accepted for priority review by ...

The Clarinda Regional Health Center has received a trio of awards recognizing the hospital's treatment of stroke and cardiac ...

CMS floats Medicare payment for AI diagnostic software, proposing a new category to standardize reimbursement for algorithm-driven clinical tools.

Introduction Tribal people in India face a growing risk of multimorbidity, primarily from cardiovascular diseases (CVD) due to changing lifestyles and unique socio-cultural and political factors. We ...

Objective Recent advances in giant cell arteritis (GCA) management aim to reduce glucocorticoid (GC). We described changes in ...

A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), working in collaboration with an ...

Genomic surveillance—the process of monitoring and sequencing pathogens—is one of the most important tools for detecting ...

In the third group-stage match of the 2026 FIFA World Cup between South Korea and South Africa, South Korea recorded a ...

Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease worldwide, applauds ...

Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...

If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...